Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity
Medullary thyroid carcinoma (MTC) is a rare aggressive form of thyroid cancer with high rates of metastasis. Sporadic and hereditary MTC are strongly driven by somatic and germline mutations, respectively, in the transmembrane REarranged during Transfection (RET) proto-oncogene, which encodes a rece...
Main Authors: | Tariq Alqahtani, Abdullah Alswied, Daekyu Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3288 |
Similar Items
-
Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
by: Qin Huang, et al.
Published: (2020-05-01) -
Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
by: Ana Luiza Maia, et al.
Published: (2011-12-01) -
RET splice site variants in medullary thyroid carcinoma
by: Daryoush Saeed-Vafa, et al.
Published: (2024-03-01) -
RET mutations in a large indian family with medullary thyroid carcinoma
by: D M Mahesh, et al.
Published: (2014-01-01) -
Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes
by: Tariq Alqahtani, et al.
Published: (2023-04-01)